Ocugen regains Nasdaq minimum bid price compliance; deficiency matter closed

Ocugen, Inc.

Received notice on July 28, 2025 that closing bid price met $1.00 minimum for ten consecutive business days July 8–25, 2025.
Previously received deficiency notice on Dec 31, 2024 and was granted extension through Dec 29, 2025.
Compliance achieved earlier than extension deadline; matter now closed by Nasdaq.
Common stock ticker OCGN continues trading on The Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.